back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-08 17:46 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Vaughan, David James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-9,000 vol |
201,000 | |
| Filed 2024-03-08 17:38 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-35,000 vol |
643,021 | |
| Filed 2024-03-08 17:27 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,666
+16,666 vol $1.00 each |
247,485 | |
| Filed 2024-03-08 17:21 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-16,666
-16,666 vol $1.00 each |
20,000 | |
| Filed 2024-03-07 16:31 Tx date 2024-03-07 |
$ATE
Antibe Therapeutics Inc. |
Curtis, Scott Wilson
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,800
+15,000 vol $0.52 each |
115,000 | |
| Filed 2024-03-07 11:49 Tx date 2024-03-07 |
$ATE
Antibe Therapeutics Inc. |
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+20,000 vol $0.50 each |
1,003,296 | |
| Filed 2024-03-06 11:38 Tx date 2024-03-06 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+24,000 vol $0.40 each |
254,819 | |
| Filed 2024-01-13 16:23 Tx date 2023-10-21 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,500 vol |
46,251 | |
| Filed 2024-01-13 16:19 Tx date 2023-10-21 |
$ATE
Antibe Therapeutics Inc. |
Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,500 vol |
65,000 | |
| Filed 2024-01-13 16:11 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,482
+11,666 vol $1.07 each |
38,334 | |
| Filed 2024-01-13 16:10 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-12,482.62
-11,666 vol $1.07 each |
1,666 | |
| Filed 2024-01-13 16:07 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,482
+11,666 vol $1.07 each |
38,334 | |
| Filed 2024-01-13 16:06 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-12,482.62
-11,666 vol $1.07 each |
1,666 | |
| Filed 2024-01-13 16:04 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,267
+13,334 vol $1.07 each |
333,334 | |
| Filed 2024-01-13 16:03 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-14,267.38
-13,334 vol $1.07 each |
1,666 | |
| Filed 2024-01-13 16:00 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$42,800
+40,000 vol $1.07 each |
95,334 | |
| Filed 2024-01-13 15:59 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-42,800
-40,000 vol $1.07 each |
1,666 | |
| Filed 2024-01-13 15:56 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,267
+13,334 vol $1.07 each |
185,136 | |
| Filed 2024-01-13 15:55 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-14,267.38
-13,334 vol $1.07 each |
1,666 | |
| Filed 2024-01-13 15:48 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,482
+11,666 vol $1.07 each |
202,819 |